Vycor Medical (VYCO) Assets Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.75% |
| Dec 31, 2025 | -1.17% |
| Sep 30, 2025 | -0.30% |
| Jun 30, 2025 | -1.16% |
| Mar 31, 2025 | 0.28% |
| Dec 31, 2024 | 2.19% |
| Sep 30, 2024 | 1.11% |
| Jun 30, 2024 | -2.15% |
| Mar 31, 2024 | 0.03% |
| Dec 31, 2023 | 0.19% |
| Sep 30, 2023 | 0.81% |
| Jun 30, 2023 | -3.61% |
| Mar 31, 2023 | -9.67% |
| Dec 31, 2022 | -7.64% |
| Sep 30, 2022 | -4.36% |
| Jun 30, 2022 | -6.92% |
| Mar 31, 2022 | -7.81% |
| Dec 31, 2021 | -3.59% |
| Sep 30, 2021 | -9.65% |
| Jun 30, 2021 | -5.72% |
| Mar 31, 2021 | -10.71% |
| Dec 31, 2020 | -12.04% |
| Sep 30, 2020 | -16.05% |
| Jun 30, 2020 | -17.84% |
| Mar 31, 2020 | -18.33% |
| Dec 31, 2019 | -9.75% |
| Sep 30, 2019 | -11.05% |
| Jun 30, 2019 | -12.45% |
| Mar 31, 2019 | -12.28% |
| Dec 31, 2018 | -22.21% |
| Mar 31, 2018 | -25.11% |
| Dec 31, 2017 | -32.75% |
| Sep 30, 2017 | -26.90% |
| Jun 30, 2017 | -27.54% |
| Mar 31, 2017 | -24.64% |
| Dec 31, 2016 | -11.12% |
| Sep 30, 2016 | -11.99% |
| Jun 30, 2016 | -8.56% |
| Mar 31, 2016 | -8.80% |
| Dec 31, 2015 | -4.69% |
| Mar 31, 2015 | -1.75% |
| Dec 31, 2014 | 10.10% |
| Sep 30, 2014 | 0.40% |
| Jun 30, 2014 | 0.22% |
| Dec 31, 2013 | -0.60% |